☆ 4.7 Article

Intrahepatic Cholangiocarcinoma and Acute Intermittent Porphyria: A Case Report

JOURNAL OF CLINICAL MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Oncology

Heterogeneous molecular behavior in liver tumors (HCC and CCA) of two patients with acute intermittent porphyria

Thomas Haverkamp et al.

Summary: Acute intermittent porphyria (AIP) is a rare metabolic disorder characterized by elevated levels of 5-aminolevulinic acid (5-ALA) and porphobilinogen (PBG). Patients with AIP have a higher risk of primary liver cancer, but the exact mechanism of carcinogenesis is unknown.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals

Mattias Lissing et al.

Summary: This study confirmed a high risk of primary liver cancer in patients with acute hepatic porphyrias (AHP), particularly in those with clinical and biochemical activity of acute intermittent porphyria (AIP). Regular surveillance for primary liver cancer is recommended for patients older than 50 years with a history of active AIP.

JOURNAL OF INTERNAL MEDICINE (2022)

添加到收藏夹

Review Clinical Neurology

Neurological Manifestations of Acute Porphyrias

Kyle Wylie et al.

Summary: This article reviews the basic principles, pathogenic mechanisms, presentations, and treatments of porphyrias, with a focus on cases with neurological manifestations. Recent findings include descriptions of posterior reversible encephalopathy syndrome, cerebral vasoconstriction, and acute flaccid paralysis.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Circadian Genes Expression Patterns in Disorders Due to Enzyme Deficiencies in the Heme Biosynthetic Pathway

Maria Savino et al.

Summary: This article investigates the relationship between heme biosynthesis disorders and altered expression of circadian genes, finding that changes in circadian gene expression may be associated with the symptoms and signs of porphyria patients.

BIOMEDICINES (2022)

添加到收藏夹

Review Oncology

Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review

Daryl Ramai et al.

Summary: Porphyria is a metabolic condition that can lead to liver cancer. Our study found that patients with porphyria are at an increased risk of developing primary liver malignancy. Therefore, routine surveillance should be conducted to detect liver cancer early in these patients.

CANCERS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the US Porphyrias Consortium

Behnam Saberi et al.

Summary: In this U.S. study, 1.5% of patients with AHP had HCC, which occurred without cirrhosis. Patients with AHP should be screened for HCC starting at age 50, regardless of clinical attacks.

HEPATOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators

Helene J. Bustad et al.

Summary: Acute intermittent porphyria (AIP) is a rare autosomal dominant inherited disease caused by mutations in the HMBS gene, leading to acute attacks and long-term complications. Treatment options are limited, but there are emerging therapeutic approaches with potential prophylactic correction of the disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Liver Transplantation for Acute Intermittent Porphyria

Mattias Lissing et al.

Summary: Liver transplantation (LT) is a curative treatment option for patients with recurrent attacks of acute intermittent porphyria (AIP). Pretransplant neurological impairment is associated with increased mortality, while pretransplant renal impairment is common but shows limited improvement post-LT.

LIVER TRANSPLANTATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications

Andrea Ricci et al.

Summary: Porphyrias are rare disorders caused by enzyme dysfunction in heme biosynthesis pathway. Acute porphyrias may present with potentially life-threatening neurovisceral attacks, with porphyria-associated kidney disease being a distinct long-term degenerating condition without a satisfactory treatment yet.

DIAGNOSTICS (2021)

添加到收藏夹

Article Anesthesiology

Acute hepatic porphyria and anaesthesia: a practical approach to the prevention and management of acute neurovisceral attacks

N. Wilson-Baig et al.

BJA EDUCATION (2021)

添加到收藏夹

Review Endocrinology & Metabolism

Heme biosynthesis and the porphyrias

John D. Phillips

MOLECULAR GENETICS AND METABOLISM (2019)

添加到收藏夹

Article Endocrinology & Metabolism

Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword

Katell Peoc'h et al.

MOLECULAR GENETICS AND METABOLISM (2019)

添加到收藏夹

Review Endocrinology & Metabolism

Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes

Makiko Yasuda et al.

MOLECULAR GENETICS AND METABOLISM (2019)

添加到收藏夹

Article Endocrinology & Metabolism

Medical and financial burden of acute intermittent porphyria

Rochus A. Neeleman et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2018)

添加到收藏夹

Review Hematology

Update review of the acute porphyrias

Penelope E. Stein et al.

BRITISH JOURNAL OF HAEMATOLOGY (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Acute Hepatic Porphyrias: Recommendations for Evaluation and Long-Term Management

Manisha Balwani et al.

HEPATOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Acute hepatic porphyria and cancer risk: a nationwide cohort study

C. M. Baravelli et al.

JOURNAL OF INTERNAL MEDICINE (2017)

添加到收藏夹

Review Medicine, General & Internal

Porphyria

D. Montgomery Bissell et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Review Medicine, Research & Experimental

Clinical, Biochemical and Molecular Characteristics of the Main Types of Porphyria

Urszula Szlendak et al.

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2016)

添加到收藏夹

Article Endocrinology & Metabolism

Cerebral Hypoperfusion in Hereditary Coproporphyria (HCP): A Single Photon Emission Computed Tomography (SPECT) Study

Guido Valle et al.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2016)

添加到收藏夹

Review Medicine, General & Internal

A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias

Paolo Ventura et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)

添加到收藏夹

Article Anesthesiology

Porphyrias: implications for anaesthesia, critical care, and pain medicine

Helen Findley et al.

BJA EDUCATION (2012)

添加到收藏夹

Article Medicine, General & Internal

Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden

E. Innala et al.

JOURNAL OF INTERNAL MEDICINE (2011)

添加到收藏夹

Article Medicine, General & Internal

Porphyrias

Herve Puy et al.

LANCET (2010)

添加到收藏夹

Article Anesthesiology

Porphyrias

MFM James et al.

BRITISH JOURNAL OF ANAESTHESIA (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.